Document is current

Any future updates will be listed below

Correction: Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma

Crossref DOI link: https://doi.org/10.1007/s11307-025-01984-8

Published Online: 2025-03-05

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark